Daiichi Sankyō (4568.T) Financial Analysis & Valuation | Quarter Chart

Daiichi Sankyō (4568.T)

4568.T
Price: $17.03
Fair Value: 🔒
🔒score
Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company offers trastuzumab deruxtecan, an anti-cancer agent and anti-HER2 antibody drug conjugate; mirogabalin for pain treatment; teneligliptin/canagliflozin for... more
Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells p... more
Description Shares
Market Cap$31.00BExchangeJPX
SectorHealthcareIndustryDrug Manufacturers - General
CountryJPCEOHiroyuki Okuzawa
IPO Date2000-01-04CAGR0.05%
Employees18,726Websitewww.daiichisankyo.com
Div. Yield2.88%Payout Ratio0.49%
Buy Back Yield3.06%Total Yield5.94%
4568.T chart loading...
Fundamentals Technicals
Enterprise Value$4930.57BP/E Ratio19.27
Forward P/EPEG Ratio-0.38
P/S Ratio2.32P/B Ratio2.99
P/CF Ratio64P/FCF Ratio-97.1
EPS$0.88EPS Growth 1Y-9.93%
EPS Growth 3Y146.56%EPS Growth 5Y259.68%
Revenue Growth 1Y12.55%Gross Margin0.68%
Operating Margin0.1%Profit Margin0.12%
ROE0.16%ROA0.06%
ROCE0.07%Current Ratio2.42
Quick Ratio1.64Cash Ratio0.51
Debt/Equity0.18Interest Coverage26.05
Altman Z Score2.88Piotroski Score5